Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma
Completed · Phase 2
Conditions studied: Leukemia, Lymphoma
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combining cytarabine and mitoxantrone in treating patients who have recurrent or refractory leukemia or lymphoma.
Key facts
- Study ID
- NCT00047021
- Run by
- Case Comprehensive Cancer Center
- People needed
- 3
- Starts
- 2001-11-01
- Expected to finish
- 2005-09-01
- Last updated by the study team
- 2010-06-11
Who can join
Age: any, up to 55. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.